THOMPSON DAVIS & CO., INC. - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2018$3,000
+200.0%
250
+100.0%
0.01%
+250.0%
Q2 2018$1,0001250.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Ibex Investors LLC 250,200$1,394,0001.15%
P.A.W. CAPITAL CORP 100,000$557,0000.67%
683 Capital Management, LLC 649,295$3,617,0000.32%
MEITAV INVESTMENT HOUSE LTD 476,190$2,652,0000.14%
Park West Asset Management LLC 363,700$2,026,0000.09%
Nantahala Capital Management 308,628$1,719,0000.08%
Laird Norton Wetherby Wealth Management, LLC 10,000$56,0000.01%
J. Goldman & Co LP 26,000$145,0000.01%
ETF MANAGERS GROUP, LLC 15,068$76,0000.01%
A.R.T. Advisors, LLC 19,244$107,0000.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders